机构:[1]Department of Ophthalmology, Beijing Children’s Hospital, National Center for Children’s Health, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China临床科室职能科室临床流行病与循证医学中心眼科首都医科大学附属北京儿童医院[2]Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing, China首都医科大学附属同仁医院
Objective To evaluate the ophthalmic phenotypes associated with T-cell immune regulator 1 (TCIRG1) mutations in Chinese patients with infantile malignant osteopetrosis (IMO). Methods and analysis 27 Chinese TCIRG1-related osteoporosis infants were enrolled using direct DNA sequencing of PCR-amplified exons. 12 cases had frameshift mutation (the frameshift mutation group, group F), and 15 cases had point mutation (the point mutation group, group P). The clinical features of the two groups were compared, including age at onset, gaze qualities, optic atrophy, optic canal stenosis and waveforms of Flash visual-evoked potential (FVEP). Results The clinical signs, except age at onset and FVFP, showed statistically significant differences between the two groups. The mean age at onset was 1.8 months in group F and 4.3 months in group P; 22 eyes (92%) with frameshift mutation and 16 (53%) with point mutation had poor gaze qualities, such as nystagmus and/or strabismus; optic atrophy was found in 16 eyes (67%) in group F and 6 (20%) in group P; the average optic canal diameter was 1.45 mm in the frameshift mutation cases, 1.87 mm in other cases; FVEP indicated that the waveforms in 10 eyes (42%) were not elicited in group F, yet five eyes (17%) in group P. Conclusion In Chinese TCIRG1-related patients of IMO, the optic canal stenosis and optic atrophy were more serious in cases with frameshift mutations. However, no differences in the conduction block of optic nerve were found between the two groups.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81272981, 81570891]; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20150201]; Science and Technology Project of Beijing Municipal Science and Technology Commission [Z151100001615052]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7151003]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]
语种:
外文
被引次数:
WOS:
PubmedID:
第一作者:
第一作者机构:[1]Department of Ophthalmology, Beijing Children’s Hospital, National Center for Children’s Health, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China[2]Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[2]Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
Cao Wenhong,Wei Wenbin,Wu Qian.Ophthalmic phenotype of TCIRG1 gene mutations in Chinese infantile malignant osteopetrosis[J].BMJ OPEN OPHTHALMOLOGY.2018,3(1):-.doi:10.1136/bmjophth-2018-000180.
APA:
Cao, Wenhong,Wei, Wenbin&Wu, Qian.(2018).Ophthalmic phenotype of TCIRG1 gene mutations in Chinese infantile malignant osteopetrosis.BMJ OPEN OPHTHALMOLOGY,3,(1)
MLA:
Cao, Wenhong,et al."Ophthalmic phenotype of TCIRG1 gene mutations in Chinese infantile malignant osteopetrosis".BMJ OPEN OPHTHALMOLOGY 3..1(2018):-